Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Investments

Latest From Investments

ViroVet gets government grant for vaccine work in poultry, ruminants

Belgian start-up ViroVet has received a grant from Flanders Innovation & Entrepreneurship (VLAIO) to spur development of its vaccine technology.

Vaccines R&D

Animalcare sees stock recovery following wholesale divestment

UK firm Animalcare has seen its shares slowly begin to recover since the divestment of its wholesale division.

Investments Operations

New outsourced R&D specialists provide animal health with convenient innovation avenue

With the animal health ecosystem broadening, it is no wonder the industry's leading companies are looking for a helping hand with innovation. Animal Pharm editor Joseph Harvey looks at a new culture of sharing.

R&D Deals

GALVmed receives aid to develop vaccine projects for Africa

GALVmed will receive $10 million in UK government aid to advance vaccine projects in Africa.

Investments R&D

Elanco targets $1.45bn IPO that could be a litmus test for animal health

Elanco has set the terms of its upcoming initial public offering (IPO), which could raise up to $1.45 billion.

Elanco Investments

Hong Kong forum to highlight the latest innovation among Asian start-ups

The latest Animal Health Innovation Asia forum will highlight some of the leading Chinese innovators and several start-ups from the wider Asia Pacific area.

Hong Kong Investments
See All